Inoviq Ltd has released a press release.
Appendix 4E
Filed with ASX ·
On 6ix: 6ix.com/news/appendix-4e-240
6ix hasn’t read this filing yet.
Earlier from Inoviq
- Quarterly Activities Report and Appendix 4C
- US Patent Issued Protecting BARD1 Ovarian Test
- Improved Performance of BARD1 Ovarian Test
- Contract Development Agreement Signed
- Voluntary Suspension
Later from Inoviq
- Bard1 Ovarian Test Results
- Development of world first BARD1 Breast Cancer Test
- Grant of Additional Chinese Patent Core BARD1 Patent Family
- Quarterly Activities Report and Cashflow
- Pause In Trading
Follow Inoviq into a list and get an email when it puts out news.
Follow Inoviq